terlipressin has been researched along with mitomycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Czejka, M; Jäger, W; Schüller, J | 1 |
| Czejka, M; Jäger, W; Schernthaner, G; Schüller, J | 1 |
3 other study(ies) available for terlipressin and mitomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[The effect of the vasoconstrictor glycylpressin on the bioavailability of mitomycin C].
Topics: Aged; Biological Availability; Drug Interactions; Humans; Lypressin; Male; Middle Aged; Mitomycin; Mitomycins; Terlipressin; Vasoconstrictor Agents | 1991 |
[Pharmacokinetics and local availability of mitomycin. The influence of vasoconstriction and chemoembolization].
Topics: Biological Availability; Chemistry, Pharmaceutical; Diffusion; Embolization, Therapeutic; Half-Life; Hepatic Artery; Humans; Liver Neoplasms; Lypressin; Mitomycin; Mitomycins; Starch; Terlipressin; Vasoconstrictor Agents | 1991 |